The HIV-1 Reverse Transcriptase A62V Mutation Influences Replication Fidelity and Viral Fitness in the Context of...

Area of Science:

• Virology
• Molecular Biology
• Drug Resistance

Background:

• HIV-1 drug resistance emerges from mutations in the viral genome during antiretroviral therapy.
• Primary mutations confer resistance, while secondary mutations may not directly confer resistance but can influence viral properties.
• The A62V substitution in HIV-1 reverse transcriptase (RT) is associated with multi-drug resistance (MDR) but its selective advantage is unclear.

Purpose of the Study:

• To investigate the hypothesis that A62V influences replication fidelity and viral fitness in HIV-1 harboring MDR mutation complexes.
• To determine the adaptive role of A62V in the context of Q151M and T69SSS MDR mutation complexes.

Main Methods:

• Single-cycle replication assays were employed to assess viral mutant frequency.
• Dual-competition fitness assays were utilized to evaluate viral fitness.
• Analysis focused on HIV-1 variants with Q151M and T69SSS MDR mutation complexes, with and without A62V.

Main Results:

• A62V was observed to increase the mutant frequency in viruses with Q151M and T69SSS MDR complexes.
• The A62V substitution significantly improved the viral fitness of replication-competent MDR HIV-1 viruses.
• These results indicate a positive impact of A62V on viral replication dynamics.

Conclusions:

• The A62V amino acid substitution plays an adaptive role in HIV-1 replication fidelity and viral fitness.
• A62V likely enhances virus persistence by improving replication efficiency in the presence of drug-selective pressure.
• Understanding the role of secondary mutations like A62V is crucial for managing HIV-1 drug resistance.